pharma · Influenza, Human · Influenza
Seqirus USA
Seqirus (Australia) Pty Ltd
Seqirus USA patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Summit, USA HQ
8 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- Summit, USA
- Employees
- 8
- Programs
- 9
- Drugs
- 19
- Patents
- 0
Seqirus USA patents
0 pharmaceutical patents indexed for Seqirus USA. 0 expire within 24 months.
Seqirus USA has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Seqirus USA have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Seqirus USA patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.